PCSK9 ANTIBODY, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

摘要

The present invention provides a PCSK9 monoclonal antibody, which is capable of specifically binding to PCSK9 and blocking the binding of PCSK9 and LDLR. The monoclonal antibody of the present invention can be used for controlling and reducing cardiovascular diseases caused by hypercholesterolemia.